Economic Undertakings

US to invest $ 70 million to improve access to COVID-19 testing, Health News, ET HealthWorld


The Biden administration has said it will invest $ 70 million to increase the availability and reduce the costs of rapid, over-the-counter COVID-19 testing in the United States as it seeks to alleviate a nationwide shortage that increased testing costs.

Strong demand for testing from U.S. employers amid the wave of Delta variants, especially with the U.S. government forcing large employers to vaccinate and test their workers weekly, has pushed up the costs of national testing programs. and local.

“Access to easy-to-use, affordable and reliable COVID tests is essential to bring peace of mind to our families, especially as winter approaches,” the US Secretary of Health and Human Rights said on Monday. Social services, Xavier Becerra.

The National Institutes of Health (NIH) will invest $ 70 million and work with the U.S. Food & Drug Administration to help speed up the review process to bring more tests to the U.S. market. The FDA is also streamlining its regulatory path for manufacturers developing over-the-counter home tests.

Separately, the US FDA said it has granted emergency use authorization for another rapid antigenic test developed by Celltrion Diatrust, bringing the total number of rapid home tests available to the public to 10.

The U.S. government has so far invested around $ 3 billion to procure rapid COVID-19 tests.


Leave a Reply

Your email address will not be published.